Application of a High-Content Screening Assay Utilizing Primary Human Lung Fibroblasts to Identify Antifibrotic Drugs for Rapid Repurposing in COVID-19 Patients

Lung imaging and autopsy reports among COVID-19 patients show elevated lung scarring (fibrosis). Early data from COVID-19 patients as well as previous studies from severe acute respiratory syndrome, Middle East respiratory syndrome, and other respiratory disorders show that the extent of lung fibros...

Descripción completa

Detalles Bibliográficos
Autores principales: Marwick, John A., Elliott, Richard J.R., Longden, James, Makda, Ashraff, Hirani, Nik, Dhaliwal, Kevin, Dawson, John C., Carragher, Neil O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Laboratory Automation and Screening. Published by Elsevier Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458684/
https://www.ncbi.nlm.nih.gov/pubmed/34078171
http://dx.doi.org/10.1177/24725552211019405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458684/
https://www.ncbi.nlm.nih.gov/pubmed/34078171
http://dx.doi.org/10.1177/24725552211019405

Ejemplares similares